Sentinel Lymph Node Biopsy in Early Breast Cancer

Breast care

Thorsten Kühn¹ 

[1] Klinik für Frauenheilkunde und Geburtshilfe, Interdisziplinäres Brustzentrum am Klinikum Esslingen, Germany

关键词: Breast cancer;    Surgery;    Axillary lymph node dissection;    Sentinel lymph node biopsy;   

DOI  :  10.1159/000329193

学科分类：泌尿医学

来源: S Karger AG

【 摘 要 】

The role of axillary surgery for the treatment of primary breast cancer is in a process of constant change. During the last decade, axillary dissection with removal of at least 10 lymph nodes (ALD) was replaced by sentinel lymph node biopsy (SLNB) as a staging procedure. Since then, the indication for SLNB rapidly expanded. Today's surgical strategies aim to minimize the rate of patients with a negative axillary status who undergo ALD. For some subgroups of patients, the indication for SLNB (e.g. multicentric disease, large tumors) or its implication for treatment planning (micrometastatic involvement, neoadjuvant chemotherapy) is being discussed. Although the indication for ALD is almost entirely restricted to patients with positive axillary lymph nodes today, the therapeutic effect of completion ALD is more and more questioned. On the other hand, the diagnostic value of ALD in node-positive patients is discussed. This article reflects today's standards in axillary surgery and discusses open issues on the diagnostic and therapeutic role of SLNB and ALD in the treatment of early breast cancer.

【 授权许可】

Unknown